Agios Pharmaceuticals
AGIO
AGIO
163 hedge funds and large institutions have $2.81B invested in Agios Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 68 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
23% less capital invested
Capital invested by funds: $3.63B → $2.81B (-$820M)
37% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 68
51% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 37
Holders
163
Holding in Top 10
2
Calls
$14.1M
Puts
$17.8M
Top Buyers
| 1 | +$19.5M | |
| 2 | +$15M | |
| 3 | +$11.8M | |
| 4 |
D.E. Shaw & Co
New York
|
+$5.51M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.54M |
Top Sellers
| 1 | -$73.3M | |
| 2 | -$56.9M | |
| 3 | -$42.4M | |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$21.4M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$18.2M |